SNN Stock Summary and Trading Ideas (Smith & Nephew Snats | NYSE:SNN)

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Snats trades on the NYSE stock market under the symbol SNN.

As of September 8, 2026, SNN stock price declined to $27.78 with 2,644,413 million shares trading.

SNN has a beta of 0.45, meaning it tends to be less sensitive to market movements. SNN has a correlation of 0.06 to the broad based SPY ETF.

SNN has a market cap of $11.63 billion. This is considered a Large Cap stock.

In the last 3 years, SNN traded as high as $38.79 and as low as $21.53.

The top ETF exchange traded funds that SNN belongs to (by Net Assets): DFIC, BINV, AVDE, DFAX, APIE.

SNN has underperformed the market in the last year with a price return of -24.1% while the SPY ETF gained +19.4%. SNN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.0% and -5.1%, respectively, while the SPY returned +1.6% and +0.2%, respectively.

SNN support price is $28.44 and resistance is $29.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNN shares will trade within this expected range on the day.